American Journal of Kidney Diseases
Volume 53, Issue 6 , Pages A37-A39 , June 2009

Quiz Page June 2009: Worsening Kidney Function With a History of Urolithiasis

References 

  1. Seshan SV, D'Agati VD, Appel GA, Churg J. Tubulo-interstitial and vascular lesions associated with metabolic diseases, in Renal Disease Classification and Atlas of Tubulointerstitial and Vascular Diseases. In: New York, NY: Lippincott Williams & Wilkins; 1999;p. 231–259
  2. WHO. Melamine and Cyanuric Acid: Toxicity, Preliminary Risk Assessment and Guidance on Levels in Food. Geneva, Switzerland: World Health Organization; 2008;
  3. Brown CA, Jeong KS, Poppenga RH, et al. Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J Vet Diagn Invest. 2007;19:525–531
  4. Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459–465
  5. Kuhara T. Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrom Rev. 2005;24:814–827
  6. Sahota A, Tischfield JA, Kamatani N, Simmonds HA. Adenine phosphoribosyltrasferase deficiency and 2,8-dihydroxyadenine lithiasis. In:  Scrivcr CR,  Beaudet AL,  Sly WS,  Valle D,  Vogelstein B,  Childs B editor. The Metabolic and Molecular Basis of lnherited Disease. (ed 8). New York, NY: McGraw-Hill; 2001;p. 2571–2584
  7. Edvardsson V, Palsson R, Olafsson I, Hjaltadottir G, Laxdal T. Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. Am J Kidney Dis. 2001;38:473–480
  8. Gagne ER, Deland E, Daudon M, Noel LH, Nawar T. Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: The first report of recurrence in a kidney transplant. Am J Kidney Dis. 1994;24:104–107

 Case provided and authored by Tomonori Kimura, MD,1,2 Keiko Yasuda, MD,1 Yoshitsugu Obi, MD,1 Ken-ichiro Kobayashi, MD,1 Tomiko Kuhara, PhD,3 Yoshitaka Isaka, MD, PhD,2 Enyu Imai, MD, PhD,2 Hiromi Rakugi, MD, PhD,2 and Terumasa Hayashi, MD, PhD,1 1Department of Nephrology, Rinku General Medical Center, Izumisano Municipal Hospital; 2Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Osaka; and 3Division of Human Genetics, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan.Address correspondence to Terumasa Hayashi, MD, PhD, Department of Nephrology, Izumisano Municipal Hospital, Rinku General Medical Center, 2-23 Rinku-Orai Kita, Izumisano, Osaka 598-8577, Japan. E-mail: t-hayashi@rgmc.izumisano.osaka.jp

 Support: None.

 Financial Disclosure: None.

PII: S0272-6386(09)00144-9

doi: 10.1053/j.ajkd.2008.12.027

American Journal of Kidney Diseases
Volume 53, Issue 6 , Pages A37-A39 , June 2009

Article Tools

* Image Usage & Resolution